FDA Ortho Panel Says 'No' To Medtronic DIAM Spine Device
This article was originally published in The Gray Sheet
Executive Summary
Minimally invasive interspinous spacer did not get the support of an FDA advisory panel in the face of serious questions about Medtronic's study design.